WallStreetZenWallStreetZen

NASDAQ: MIST
Milestone Pharmaceuticals Inc Stock Ownership - Who owns Milestone Pharmaceuticals?

Insider buying vs selling

Have Milestone Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when MIST insiders and whales buy or sell their stock.

MIST Shareholders

What type of owners hold Milestone Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Rtw Investments LP14.25%7,571,204$13.70MInsider
Blackrock Inc6.15%3,270,749$5.92MInstitution
Rtw Investments LP6.13%3,256,102$5.89MInstitution
Holdings A. Novo4.58%2,434,470$4.41MInsider
De Solidarite Des Travailleurs Du Quebec Fonds4.24%2,254,920$4.08MInsider
Alta Fundamental Advisers LLC3.14%1,671,289$3.03MInstitution
Lion Point Capital LP3.10%1,650,207$2.99MInstitution
Millennium Management LLC2.81%1,494,489$2.71MInstitution
Goldman Sachs Group Inc2.55%1,353,067$2.45MInstitution
Bleichroeder LP2.49%1,326,085$2.40MInstitution

1 of 3

MIST vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MIST33.44%24.16%
ACHV12.89%44.73%Net SellingNet Buying
CELU4.67%95.33%Net BuyingNet Buying
ANTX54.22%45.78%Net BuyingNet Selling
CVM12.96%43.80%Net BuyingNet Buying

Milestone Pharmaceuticals Stock Ownership FAQ

Who owns Milestone Pharmaceuticals?

Milestone Pharmaceuticals (NASDAQ: MIST) is owned by 33.44% institutional shareholders, 24.16% Milestone Pharmaceuticals insiders, and 42.40% retail investors. Rtw Investments LP is the largest individual Milestone Pharmaceuticals shareholder, owning 7.57M shares representing 14.25% of the company. Rtw Investments LP's Milestone Pharmaceuticals shares are currently valued at $13.63M.

If you're new to stock investing, here's how to buy Milestone Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.